ADRA2C anticorps (Extracellular Domain, N-Term)

N° du produit ABIN1731581

L’anticorps Lapin Polyclonal anti-ADRA2C a été validé pour IHC (p). Il convient pour détecter ADRA2C dans des échantillons de Humain.

Aperçu rapide pour ADRA2C anticorps (Extracellular Domain, N-Term) (ABIN1731581)

Antigène: ADRA2C (Adrenergic, alpha-2C-, Receptor (ADRA2C))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ADRA2C est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-ADRA2C anticorps

Épitope: Extracellular Domain, N-Term

Specificité: Reacts with human ADRA2C

Réactivité croisée (Details): BLAST analysis of the peptide immunogen showed no homology with other human proteins.

Purification: Antigen affinity purified

Immunogène: Synthetic 18 amino acid peptide from N-terminal extracellular domain of human ADRA2C. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Gibbon (100%), Monkey (100%), Dog (89%), Rat (83%), Guinea pig (83%).

Isotype: IgG

Information d'application

Indications d'application:

Working dilution: IHC - P (26 μg/mL

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS, Sodium azide 0.1 %

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C/-80 °C

Stockage commentaire: Long term: -70°C, Short term: +4°C

Détails sur ADRA2C

Antigène: ADRA2C (Adrenergic, alpha-2C-, Receptor (ADRA2C))

Autre désignation: ADRA2C

Sujet: Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins.

UniProt: P18825

Pathways: EGFR Signaling Pathway, cAMP Metabolic Process